Literature DB >> 11007306

Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.

T Terada1, K Sawada, M Irie, H Saito, Y Hashimoto, K Inui.   

Abstract

Peptide transporters PEPT1 and PEPT2 transport numerous compounds including small peptides, peptide-like drugs and nonpeptidic compounds such as valacyclovir. PEPT1 and PEPT2 show low and high affinity for most substrates, respectively, but beta-lactam antibiotics without an alpha-amino group are the only known substrates that prefer PEPT1 to PEPT2. The aim of this study was to compare the recognition and affinity of various substrates between rat PEPT1 and rat PEPT2, and to determine the structural requirements influencing the substrate affinity. [14C]Glycylsarcosine uptake by PEPT1- or PEPT2-expressing transfectant was inhibited by di- and tripeptides, but not by amino acids, tetrapeptides or most cyclic dipeptides. All dipeptides and tripeptides examined showed more potent inhibition of [14C]glycylsarcosine uptake via PEPT2 than via PEPT1, irrespective of their charge and structure. Modification of the alpha-amino group of dipeptides reduced their substrate affinity to both transporters, as compared to unmodified dipeptides, but these dipeptides still showed potent inhibitory effects on PEPT2. Among the nonpeptidic substrates tested, only the eight-amino-octanoic acid displayed stronger inhibition of [14C]glycylsarcosine uptake in PEPT1 than in PEPT2. These findings suggest that alpha- or beta-amino carbonyl function is the key structure responsible for the higher affinity for PEPT2 than for PEPT1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007306     DOI: 10.1007/s004240000339

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  18 in total

1.  Development of a peptide-drug conjugate for prostate cancer therapy.

Authors:  Wanyi Tai; Ravi S Shukla; Bin Qin; Benyi Li; Kun Cheng
Journal:  Mol Pharm       Date:  2011-05-03       Impact factor: 4.939

2.  Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.

Authors:  Monica Sala-Rabanal; Donald D F Loo; Bruce A Hirayama; Eric Turk; Ernest M Wright
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

3.  Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line.

Authors:  Carsten Uhd Nielsen; Claudiu T Supuran; Andrea Scozzafava; Sven Frokjaer; Bente Steffansen; Birger Brodin
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 4.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

5.  Demonstration of functional dipeptide transport with expression of PEPT2 in guinea pig cardiomyocytes.

Authors:  Hua Lin; Nicola King
Journal:  Pflugers Arch       Date:  2006-11-21       Impact factor: 3.657

6.  Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.

Authors:  Miyako Okamura; Tomohiro Terada; Toshiya Katsura; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice.

Authors:  Huidi Jiang; Yongjun Hu; Richard F Keep; David E Smith
Journal:  J Neurochem       Date:  2009-04-04       Impact factor: 5.372

8.  Renal disposition of colistin in the isolated perfused rat kidney.

Authors:  Zheng Ma; Jiping Wang; Roger L Nation; Jian Li; John D Turnidge; Kingsley Coulthard; Robert W Milne
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

9.  Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice.

Authors:  Mohamed A Kamal; Huidi Jiang; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.